Banmeet Anand
Corporate Officer/Principal chez HARPOON THERAPEUTICS, INC.
Profil
Banmeet Anand is currently the Senior Vice President-Translational Medicine at Harpoon Therapeutics, Inc. Prior to this, he worked as the Vice President & Head-Nonclinical Development at Molecular Templates, Inc. He holds a doctorate degree from the University of Missouri.
Postes actifs de Banmeet Anand
Sociétés | Poste | Début |
---|---|---|
HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 06/07/2022 |
Anciens postes connus de Banmeet Anand
Sociétés | Poste | Fin |
---|---|---|
MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - |
Formation de Banmeet Anand
University of Missouri | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |